Coronary revascularization with PCI or CABG surgery results in comparable clinical outcomes at 10 years in patients with left main coronary artery disease and low-to-intermediate anatomic complexity, but there is a survival advantage with surgery in patients with the most complex anatomy, according to long-term follow-up of the MAIN-COMPARE registry.
Led by Yong-Hoon Yoon, MD (Chungnam National University Hospital, Daejeon, South Korea), and published today in JACC: Cardiovascular Interventions, the investigators reported that for individuals with a low-to-intermediate SYNTAX score, all-cause mortality and the combined endpoint of death, MI, or stroke were not statistically different between patients treated with PCI or CABG surgery, although rates of target vessel revascularization were higher with PCI.
In patients with complex anatomy, as indicated by a high SYNTAX score, the risk of all-cause mortality was significantly higher with PCI than with CABG surgery, as was the rate of target vessel revascularization. There was a nonsignificant trend toward a higher risk of death, MI, or stroke with PCI.
David Kandzari, MD (Piedmont Heart Institute, Atlanta, GA), the lead US interventional investigator for the EXCEL trial comparing CABG surgery versus PCI in patients with left main CAD, said extended follow-up from MAIN-COMPARE is a welcome addition to the field as well as a reflection of current clinical practice. For patients with left main CAD and low-to-intermediate lesion complexity, there is a discussion with the heart team about treatment options with PCI or CABG surgery, he said. As disease complexity increases, the choice for surgery is clear.
I did a patient last night, my last case of the day, where he had left main disease but the disease was so complex there was no decision other than to recommend bypass surgery for him, Kandzari told TCTMD. Having said that, these data, along with EXCEL, should be interpreted as very reassuring of the long-term safety and durability of left main stenting compared with surgery in patients with low-to-intermediate complexity.
Kevin Bainey, MD (Mazankowski Alberta Heart Institute, Edmonton, Canada), said that at his institution patients with left main CAD are reviewed by interventional cardiologists and surgeons as part of the heart-team approach to care. In those discussions, the SYNTAX score does come into play when making treatment decisions, although a gestalt-type approach is often employed, he added.
Like Kandzari, Bainey cited the 10-year follow-up from the SYNTAX trial showing clinical equipoise between CABG and PCI in patients with left main CAD but also said this latest analysis is helpful in that justifies how physicians are currently practicing as a heart team. Most patients with low-to-intermediate anatomic complexity choose PCI over CABG, he told TCTMD. Even so, its quite clear that in the high-SYNTAX-score patients, we do think the cases need to be peer reviewed and we do still also believe that CABG is a better approach for those patients.
MAIN-COMPARE
The MAIN-COMPARE registry included 2,240 patients with unprotected left main CAD treated between 2000 and 2006, of whom 660 were excluded from analysis because they did not have a SYNTAX score. Of the remaining 1,580 patients, 897 had a low-to-intermediate SYNTAX score ( 32) and 683 had a high SYNTAX score ( 33). In the low-to-intermediate and high groups, 71% and 27% of patients were treated with PCI, respectively.
In addition to differences in clinical events, the researchers found that the SYNTAX score had incremental prognostic value on the 10-year risk of outcomes in the PCI-treated patients, but not in those treated with surgery. In the PCI group, a high SYNTAX score was associated with increased risks of death (HR 1.59; 95% CI 1.06-2.38), the composite of death, Q-wave MI, or stroke (HR 1.59; 95% CI 1.08-2.32), and target lesion revascularization (HR 1.57; 95% CI 1.01-2.44) compared with a low score.
Adjusted Risks for 10-Year Outcomes
CABG
PCI
P Value
Death
SYNTAX Score 32
SYNTAX Score 33
17.7%
23.8%
19.3%
31.3%
0.589
0.048
Death/Q-wave MI/Stroke
SYNTAX Score 32
SYNTAX Score 33
18.8%
27.5%
21.6%
33.7%
0.352
0.123
TVR
SYNTAX Score 32
SYNTAX Score 33
4.5%
4.0%
19.7%
29.2%
< 0.001
< 0.001
In their paper, Yoon and colleagues note that their results are at odds with EXCEL and NOBLE, the other trial comparing CABG versus PCI in patients with left main CAD. In those trials, the anatomic SYNTAX score did not have any impact on relative clinical outcomes after PCI and CABG, limiting the clinical utility of the SYNTAX score in left main coronary artery revascularization. However, as they and Kandzari point out, patients with a large degree of anatomic complexity were excluded from EXCEL and NOBLE.
Bernard Chevalier, MD (Hpital Priv Jacques Cartier, Massy, France), who wrote an editorial accompanying the study, notes that PCI has evolved over time, with patients treated with better stents and improved dual antiplatelet therapy, among other developments. Thus, enhanced stenting strategies seem to partly play a role of equalizer in terms of hard safety endpoints in patients with heavy coronary burden, he writes.
To TCTMD, Kandzari said the 10-year MAIN-COMPARE results are in line with the SYNTAX trial showing that the greater the anatomic complexity, the greater the benefit of bypass surgery. He noted, however, that more and more data indicate that completeness of coronary revascularization is the driver of improved outcomes, and that if physicians can achieve complete revascularization with PCI akin to that achieved with CABG surgery, outcomes would be similar.
I think that in this case the findings speak not so much to the baseline complexity as a predictor of adverse outcomes, but more to what is not reported in this study, which is residual disease, he said. In other words, the incompleteness of revascularization that is more common with PCI than with bypass surgery. This study unfortunately doesnt address the residual SYNTAX score or the completeness of revascularization.
Kandzari also noted that a paradox has been observed in interventional cardiology where physicians treat less coronary disease in patients with greater disease burden or anatomic complexity, such as in patients with chronic total occlusions, bifurcations, or calcified lesions. The driver of adverse clinical outcomes in these instances is not so much what gets treated, but what gets left behind, said Kandzari.
MAIN-COMPARE, EXCEL, and Other Trials
Compared with EXCEL, a trial that has been heavily criticized by one former investigator and several professional surgical societies, MAIN-COMPARE was nonrandomized and included a broader range of less selected patients. In EXCEL at 5 years, said Kandzari, the difference in repeat revascularization also favored surgery, but the absolute difference in event rates was approximately 7%. In contrast, the observed difference in target lesion revascularization between PCI and surgery in the low-to-intermediate SYNTAX score patients was roughly 15%.
So, I think part of this highlights that these are probably more complex patients than were included in the EXCEL trial, said Kandzari.
He pointed out that the prevalence of diabetes was similar in the PCI and surgery cohorts in MAIN-COMPARE, despite the large body of evidence showing an advantage with CABG surgery in these patients. The FREEDOM trial, a large-scale study showing a lower risk of mortality with surgery in diabetic patients and multivessel CAD, wasnt yet available when the patients were treated and enrolled in the MAIN-COMPARE registry, however.
Bainey said it can be a challenge to convince patients they are more appropriate candidates for surgery. For those with complex anatomy, though, a discussion with surgeon and interventional cardiologist usually helps convince them that surgery is the better approach. In terms of potential for conflict between surgeons and interventionalistssome of which has been on full display on social media in light of the EXCEL controversylong-term data from MAIN-COMPARE help reinforce the benefits of PCI in selected patients.
Its powerful data for us, and it actually compounds with other data showing that what were doing makes sense, said Bainey.
In addition to anatomic complexity, patient comorbidities and age factor into treatment decisions, which can sometimes lead to differing opinions between surgeons and interventionalists on the best treatment option. The comorbidities may be prohibitive for surgery and it falls upon us to treat, said Bainey. The SYNTAX score is great in patients where youre not taking into consideration other clinical parameters. Its great if the patient is 65 and doesnt have much in the way of other comorbidities, but a high SYNTAX score in an 85-year-old with renal failure and bad lungsthat patient is not going to go for CABG.
To TCTMD, Kandzari said rates of left main PCI have remained low and relatively stagnant over the last couple of years despite the positive data from EXCEL at 3 and 5 years. He added that he doesnt think the controversy around the trial dampened enthusiasm for PCI in appropriately selected patients, noting that the debate around EXCEL emerged only in the last few months.
Follow this link:
SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE - TCTMD
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com [Last Updated On: April 12th, 2018] [Originally Added On: April 12th, 2018]
- Cardiology | Weill Cornell Medicine [Last Updated On: April 14th, 2018] [Originally Added On: April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... [Last Updated On: May 15th, 2018] [Originally Added On: May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... [Last Updated On: May 16th, 2018] [Originally Added On: May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic [Last Updated On: May 27th, 2018] [Originally Added On: May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... [Last Updated On: June 23rd, 2018] [Originally Added On: June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- About Us - New Jersey Cardiology Associates [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- About Us - Ventura Clinical Trials [Last Updated On: August 16th, 2018] [Originally Added On: August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... [Last Updated On: August 22nd, 2018] [Originally Added On: August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology [Last Updated On: December 7th, 2018] [Originally Added On: December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... [Last Updated On: December 12th, 2018] [Originally Added On: December 12th, 2018]
- Clinical Cardiology - Baptist Health [Last Updated On: December 30th, 2018] [Originally Added On: December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology [Last Updated On: February 5th, 2019] [Originally Added On: February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine [Last Updated On: March 10th, 2019] [Originally Added On: March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]